Concepedia

Holly A. Read

HA

Statistics

Publications

7

Citations

441

H-Index

7

Active since

2004

Affiliations

Eli Lilly (United States)(Current)

Holly A. Read is an author at Eli Lilly (United States) specializing in medicine, psychopharmacology, and psychiatry.

Top concepts

Publications per year

2004–2017

7

Publications

7

CYP2D6 and Clinical Response to Atomoxetine in Children and Adolescents With ADHD

David Michelson, Holly A. Read, Dustin Ruff et al. · Journal of the American Academy of Child & Adolescent Psychiatry · 2007 · 155 citations

, , +10

Hepatic Events Associated with Atomoxetine Treatment for??Attention-Deficit??Hyperactivity Disorder

Mark E. Bangs, Ling Jin, Shuyu Zhang et al. · Drug Safety · 2008 · 66 citations

, , +9

Long‐term safety of adalimumab in clinical trials in adult patients with Crohn's disease or ulcerative colitis

Jean‐Frédéric Colombel, William J. Sandborn, Walter Reinisch et al. · Alimentary Pharmacology & Therapeutics · 2017 · 61 citations · Full text

Atomoxetine Hydrochloride: Clinical Drug-Drug Interaction Prediction and Outcome

John‐Michael Sauer, Amanda Long, Barbara J. Ring et al. · Journal of Pharmacology and Experimental Therapeutics · 2004 · 55 citations

Characterisation of Mucosal Healing with Adalimumab Treatment in Patients with Moderately to Severely Active Crohn’s Disease: Results from the EXTEND Trial

Walter Reinisch, Jean‐Frédéric Colombel, Geert D’Haens et al. · Journal of Crohn s and Colitis · 2016 · 41 citations · Full text

1–5 of 7